The firm said that a strong start to the commercialization of its Liaison Plex platform also aided growth in its molecular diagnostics business.
Archimed has bought BioVendor, with plans to build and internationalize the Czech diagnostics company. Archimed sees ...
Bert Janssens takes the Europe spot and Eric Liu takes North America. Franzén, who succeeds Christian Sinding as CEO ...
Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the only DLBCL MRD ...
A study published in November in the American Journal of Clinical Pathology that Emerson co-authored validated the analyzer against the Sysmex XN Automated Hematology System and found that CytoChip's ...
The assay leverages the same powerful technology as prior versions ... is currently available for clinical use as a laboratory-developed test (LDT) performed at Adaptive's CLIA-certified lab in ...
Bio-Techne Corporation today announced that it has begun shipping the Leotm System, powered by Simple Westerntm Technology. Leo expands upon existing Simple Western platforms that offer automated ...
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has introduced the aPAP ClearPath Dried Blood Spot (DBS) Test in the United States ...
today announced plans to launch its validated flagship live cell ChemoFx® drug response assay in Europe and expanded availability in the United States. The ChemoFx® treatment Acquisition ...
This maternal serum biorepository’s primary use is in research with recent studies from serum including analysis of microbial DNA from women with and without preterm birth and design of an assay to ...
Despite insufficient evidence to support direct-to-consumer genetic testing in routine clinical care, cardiovascular clinicians increasingly face questions about its utility and interpretation because ...
Fujirebio has been working on developing immunoassay reagents and systems for many years. In particular, the company developed its Lumipulse system, which was one of the world’s first fully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results